You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

JAK-STAT

Showing 1 - 25 of 362
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kohlmeier Degos Disease With Neurologic Involvement Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

Recruiting
  • Kohlmeier Degos Disease With Neurologic Involvement
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 23, 2023

JAK/STAT Pathway in Sarcoidosis Granuloma Cells

Recruiting
  • Sarcoidosis
  • JAK-STAT Pathway Deregulation
  • Blood sample
  • Bobigny, France
    Service de pneumologie Hôpital Avicenne
Oct 3, 2022

Rheumatoid Arthritis Trial ("apigenin" and "glycyrrhizin", "glycyrrhizin" and "boswellic acid", "")

Not yet recruiting
  • Rheumatoid Arthritis
  • "apigenin" and "glycyrrhizin"
  • +2 more
  • (no location specified)
Mar 27, 2023

Synovial and Adipose Tissue Composition in Overweight/Obese

Active, not recruiting
  • Rheumatoid Arthritis
  • Assessment of synovial- and adipose tissue-derived inflammatory biomarkers
  • Rome, Italy
    Division of Rheumatology
Mar 2, 2023

JAK-STAT Signaling Pathway in Pyoderma Gangrenosum

Not yet recruiting
  • Pyoderma Gangrenosum
  • +2 more
  • immunohistochemical methods
  • (no location specified)
Mar 21, 2022

Rheumatoid Arthritis Trial in Montpellier (Blood sample analysis of patients treated as standard care)

Recruiting
  • Rheumatoid Arthritis
  • Blood sample analysis of patients treated as standard care
  • Montpellier, France
    University Hospital of Montpellier
Jan 12, 2022

ANCA Associated Vasculitis, Drug Use, JAK-STAT Pathway Deregulation Trial in Shanghai (Tofacitinib)

Completed
  • ANCA Associated Vasculitis
  • +2 more
  • Shanghai, Shanghai, China
    Department of Rheumatology in Zhongshan hospital, Fudan Universi
Jul 20, 2021

Head and Neck Squamous Cell Carcinoma Trial in Tucson, San Francisco (Ruxolitinib)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Tucson, Arizona
  • +1 more
Sep 22, 2022

Androgenetic Alopecia and the JAK-STAT Pathway

Completed
  • Androgenetic Alopecia
  • Punch skin biopsy
  • Cairo, Egypt
    Cairo University
Jan 25, 2020

Lymphoma Trial in United States (Ruxolitinib)

Recruiting
  • Lymphoma
  • Miami, Florida
  • +9 more
Oct 5, 2022

Rheumatoid Arthritis Patients Treated With JAK-inhibitor

Recruiting
  • Rheumatoid Arthritis
  • Upadacitinib <15 MG [Rinvoq]
  • Montpellier, France
    CHU de Montpellier
Jan 12, 2022

Vitiligo, Generalized Trial (Baricitinib)

Not yet recruiting
  • Vitiligo, Generalized
  • (no location specified)
Jul 7, 2023

Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +4 more
  • Utrecht, Netherlands
    Princess Máxima Center for Pediatric Oncology
Feb 16, 2023

Metastatic Triple-Negative Breast Carcinoma, Breast Cancer Trial in Dallas (Neratinib Oral Tablet, Ruxolitinib Oral Tablet)

Not yet recruiting
  • Metastatic Triple-Negative Breast Carcinoma
  • Breast Cancer
  • Neratinib Oral Tablet
  • Ruxolitinib Oral Tablet
  • Dallas, Texas
    Baylor University Medical Center, Baylor Charles A Sammons Cance
Aug 22, 2023

Rheumatoid Arthritis Trial in Leeds (Tocilizumab, Methotrexate)

Completed
  • Rheumatoid Arthritis
  • Leeds, West Yorkshire, United Kingdom
    Leeds Teaching Hospitals NHS Trust
Nov 5, 2019

Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts

Not yet recruiting
  • Warts
  • Detection of expression of SOCS3 gene
  • +2 more
  • (no location specified)
Mar 12, 2023

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,

Recruiting
  • Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Lymphoma
  • Palo Alto, California
  • +6 more
May 2, 2022

Ruxolitinib in Patients With Myelofibrosis

Not yet recruiting
  • Myelofibrosis
  • (no location specified)
Feb 28, 2023

Alopecia Areata Trial in Assiut (Betamethasone Valerate 0.1% Cream, Pentoxifylline, Metformin)

Not yet recruiting
  • Alopecia Areata
  • Betamethasone Valerate 0.1% Cream
  • +2 more
  • Assiut, Egypt
    Assiut university
Oct 15, 2023

Advanced Hepatocellular Carcinoma Trial in London (Itacitinib (INCB039110))

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Itacitinib (INCB039110)
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Jul 14, 2022

Carotid Plaque Burden in Philadelphia Negative

Recruiting
  • Myeloproliferative Neoplasm
    • Sohag, Egypt
      Faculty of Medicine
    Aug 14, 2023

    Action of Interferon in Treatment of Myeloproliferative

    Recruiting
    • Myeloproliferative Neoplasm
      • Villejuif, Ile De France, France
        Inserm U1287
      Apr 28, 2023

      Hair Loss/Baldness, Androgenic Alopecia, Male Pattern Baldness Trial in Kaohsiung (SF DNA extraction composition, Placebo)

      Completed
      • Hair Loss/Baldness
      • +3 more
      • SF DNA extraction composition
      • Placebo
      • Kaohsiung, Taiwan
        Kaohsiung Municipal Ta-Tung Hospital
      Jul 8, 2022

      Relapsed/Refractory Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Leukemia Trial in France

      Recruiting
      • Relapsed/Refractory Acute Lymphoblastic Leukemia
      • T-cell Acute Lymphoblastic Leukemia
        • Amiens, France
        • +30 more
        Apr 14, 2023

        Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)

        Active, not recruiting
        • Myelofibrosis
        • Polycythemia Vera
        • Phoenix, Arizona
        • +4 more
        Jun 20, 2022